Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Chinese Patent Office
Express Scripts
Cantor Fitzgerald

Generated: September 20, 2017

DrugPatentWatch Database Preview

LUNESTA Drug Profile

« Back to Dashboard

What is the patent landscape for Lunesta, and what generic Lunesta alternatives are available?

Lunesta is a drug marketed by Sunovion Pharms Inc and is included in one NDA.

The generic ingredient in LUNESTA is eszopiclone. There are twenty drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the eszopiclone profile page.

Summary for Tradename: LUNESTA

Suppliers / Packagers: see list11
Bulk Api Vendors: see list45
Clinical Trials: see list21
Patent Applications: see list1,002
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LUNESTA at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sunovion Pharms Inc
TABLET;ORAL021476-001Dec 15, 2004ABRXYesNo► Subscribe► Subscribe► Subscribe
Sunovion Pharms Inc
TABLET;ORAL021476-002Dec 15, 2004ABRXYesNo► Subscribe► Subscribe► Subscribe
Sunovion Pharms Inc
TABLET;ORAL021476-003Dec 15, 2004ABRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: LUNESTA

Paragraph IV activity for: LUNESTA

Drugname Dosage Strength RLD Submissiondate
eszopicloneTablets1 mg, 2 mg and 3 mgLunesta12/15/2008
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo
Harvard Business School
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus